Q4 Tech Earnings: Will CapEx Take Bite of Profits?

Published on January 31, 2025

Guidance and spending will be important to watch as analysts have their eyes on annual revenue growth, especially after news of DeepSeek shocked U.S. markets.

Continue reading on website
Other news

From Underperformance to Opportunity: Biotech's Case for 2025

January 31, 2025
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking innovations like mRNA cancer vaccines and CRISPR-based therapies.

2025 Equity and Volatility Outlook: Is the US Equity Investor at a Crossroad?

January 31, 2025
Investors may be at a crossroad in early 2025. US equities have recovered from the 2022 bear market with two exceptional years of +25% returns.